Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Reconciliation of Packaging Materials Post-Production – V 2.0

Posted on By

Tablets: SOP for Reconciliation of Packaging Materials Post-Production – V 2.0

Standard Operating Procedure for Reconciliation of Packaging Materials Post-Production

Department Tablet
SOP No. SOP/TAB/246/2025
Supersedes SOP/TAB/246/2022
Page No. Page 1 of 6
Issue Date 01/07/2026
Effective Date 06/07/2026
Review Date 01/07/2027

1. Purpose

The purpose of this SOP is to provide a systematic approach for reconciling packaging materials used during production. This ensures that the usage of packaging materials aligns with the production plan, preventing overuse, wastage, or discrepancies. Proper reconciliation contributes to inventory control, cost management, and adherence to GMP standards.

2. Scope

This SOP applies to all packaging materials used in tablet production, including primary and secondary packaging materials. It covers the reconciliation process that occurs post-production, once the production batch is completed and ready for packaging.

3. Responsibilities

  • Packaging Operators: Responsible for accurately recording packaging material usage during the production process and ensuring the correct amount of material is available for reconciliation.
  • Inventory Control Team: Responsible for performing the reconciliation process, ensuring that the physical stock matches the usage data, and updating inventory records accordingly.
  • Production Manager: Responsible for overseeing the reconciliation process and ensuring that any discrepancies are investigated and resolved.
  • Quality Control (QC): Ensure that the reconciliation process follows SOPs and complies with GMP regulations, especially when discrepancies occur.

4. Accountability

The Production Manager is accountable for ensuring that the reconciliation process is carried out effectively and promptly after each production batch. Any discrepancies found during reconciliation should be reported to the QA team for further investigation.

See also  Tablets: SOP for Batch-to-Batch Consistency Monitoring in Granulation - V 2.0

5. Procedure

5.1 Preparation for Reconciliation

  1. At the end of the production batch, gather all packaging materials used during the process (e.g., cartons, labels, blister packs, seals) (Annexure-1).
  2. Verify that the packaging material usage records are complete and accurate, as recorded during the production run (Annexure-2).
  3. Ensure that all leftover packaging materials are properly stored and accounted for (Annexure-3).

5.2 Material Count and Inventory Update

  1. Physically count all packaging materials that were used during production, and compare them with the recorded quantities (Annexure-4).
  2. Verify that all materials are used according to the production plan. If there are discrepancies, identify the cause and investigate (Annexure-5).
  3. Update the inventory records with the actual usage quantities, including any discrepancies or adjustments (Annexure-6).

5.3 Reconciliation of Leftover Packaging Materials

  1. Reconcile any unused packaging materials and determine whether they can be reused or should be discarded (Annexure-7).
  2. If materials are to be reused, they must be inspected for damage and quality before being returned to stock (Annexure-8).
  3. Record all leftover materials and update the inventory to reflect the remaining stock accurately (Annexure-9).

5.4 Discrepancy Investigation

  1. If discrepancies are found during reconciliation, investigate the root cause. This may involve checking records, reviewing usage logs, and speaking with the operators (Annexure-10).
  2. Document the findings and corrective actions taken (Annexure-11).
  3. Report significant discrepancies to the Production Manager and QA for further review and corrective action (Annexure-12).

5.5 Documentation and Record-Keeping

  1. Document all reconciliation activities, including material usage, leftover materials, discrepancies, and corrective actions (Annexure-13).
  2. Ensure that all reconciliation records are maintained according to company policies and retained for the required period (Annexure-14).
See also  Tablets: SOP for Setup and Validation of Semi-Automatic Tablet Press - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • FIFO: First In, First Out

7. Documents

  1. Packaging Material Usage Log (Annexure-1)
  2. Material Usage Record (Annexure-2)
  3. Leftover Material Log (Annexure-3)
  4. Physical Material Count Log (Annexure-4)
  5. Discrepancy Log (Annexure-5)
  6. Inventory Update Record (Annexure-6)
  7. Leftover Material Inspection Log (Annexure-7)
  8. Material Reconciliation Report (Annexure-8)
  9. Corrective Action Log (Annexure-9)
  10. Reconciliation Investigation Log (Annexure-10)
  11. Discrepancy Investigation Report (Annexure-11)
  12. Report of Corrective Actions Taken (Annexure-12)
  13. Reconciliation Documentation Log (Annexure-13)
  14. Packaging Material Records Retention Log (Annexure-14)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (FDA)
  • USP <1079> – Good Storage and Distribution Practices
  • ISO 9001 – Quality Management Systems

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Packaging Material Usage Log

Material Type Quantity Used Batch Number Operator
Blister Packs 5000 Batch 12345 John Doe

Annexure-2: Material Usage Record

Material Quantity Used Production Date Operator
Cartons 1000 01/07/2026 Jane Smith

Annexure-3: Leftover Material Log

Material Quantity Leftover Batch Number Disposition
Blister Packs 500 Batch 12345 Reused in next batch

Annexure-4: Physical Material Count Log

Material Type Quantity Counted Batch Number Operator
Cartons 1000 Batch 12345 John Doe

Annexure-5: Discrepancy Log

Material Type Quantity Discrepancy Batch Number Investigation Outcome
Blister Packs 50 Batch 12345 Found during reconciliation; reported for further investigation

Annexure-6: Inventory Update Record

Material Initial Quantity Quantity Used Quantity Leftover Updated Quantity
Cartons 1500 1000 500 500

Annexure-7: Leftover Material Inspection Log

Material Quantity Leftover Inspection Date Inspector Inspection Result
Blister Packs 500 02/07/2026 Jane Smith Pass; suitable for reuse

Annexure-8: Material Reconciliation Report

Material Type Initial Quantity Quantity Used Quantity Leftover Discrepancy
Cartons 1500 1000 500 None

Annexure-9: Corrective Action Log

Issue Action Taken Responsible Person Date
Material Discrepancy Rechecked material counts and updated inventory records John Doe 02/07/2026

Annexure-10: Reconciliation Investigation Log

Discrepancy Found Investigation Date Responsible Person Investigation Outcome
50 blister packs missing 02/07/2026 Jane Smith Reported to QA for further investigation

Annexure-11: Discrepancy Investigation Report

Discrepancy Investigation Outcome Corrective Action Taken Investigated By
Missing Blister Packs Inventory was updated incorrectly due to data entry error Updated inventory records and cross-checked against production data John Doe

Annexure-12: Report of Corrective Actions Taken

Corrective Action Action Taken Action Date Responsible Person
Material Discrepancy Rechecked stock, reconciled inventory 02/07/2026 Jane Smith

Annexure-13: Reconciliation Documentation Log

Document Type Document Reference Number Document Date
Reconciliation Report RECON-12345 02/07/2026

Annexure-14: Packaging Material Records Retention Log

Material Type Retention Period Stored By Storage Location
Cartons 5 years John Doe Storage Area A, Shelf 3

15. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP creation New procedure QA Head
01/07/2026 2.0 Updated reconciliation procedures and reporting logs Process optimization and addition of new corrective action procedures QA Head
See also  Tablets: SOP for Adhesion Testing of Coated Tablets During Production - V 2.0
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: SOP for Managing Design History Files (DHF)
Next Post: BA-BE Studies: SOP for Monitoring Ambient Conditions of Sample Freezers – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version